CHI HEALTH - MERCY CORNING — Hospital Ledger

45 CFR § 180 compliance

A · 100

This hospital published most of what § 180 requires.

●Machine-readable file published

●Gross / standard charges

●Discounted cash price

●Payer-specific negotiated rates

●Min / max negotiated charges

●Free, public, no login required

Procedures listed

11,000

Insurances with rates

CPT / HCPCS codes

7,408

Source MRF

json ↗

Most expensive procedures (gross)

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$286,442	$358,053	$584,820	19
J0225	VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE	$596,755	$286,442	$256,605	$584,820	30
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$114,000	$142,500	$232,750	19
A9513	LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION	$237,500	$114,000	$279	$232,750	32
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$104,800	$131,000	$213,966	19
J1823	INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION	$218,333	$104,800	$474	$213,966	32
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$99,077	$123,846	$202,281	19
J2351	OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23000 UNIT/23 ML SUBCUT SOLN	$206,410	$99,077	$88,756	$202,281	30
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$98,818	$123,522	$201,753	19
C9293	GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION	$205,870	$98,818	$385	$201,753	32
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$85,221	$106,526	$173,993	19
J9228	IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION	$177,544	$85,221	$189	$173,993	32
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$61,360	$76,700	$125,276	19
J1747	SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION	$127,833	$61,360	$54,968	$125,276	30
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$51,840	$64,800	$105,840	19
J2327	RISANKIZUMAB-RZAA 150 MG/ML SUBCUTANEOUS SYRINGE	$108,000	$51,840	$46,440	$105,840	30
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$47,314	$59,143	$96,600	19
J2350	OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION	$98,572	$47,314	$58.76	$96,600	32
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$43,366	$54,208	$88,540	19
J9309	POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION	$90,347	$43,366	$136	$88,540	32
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$41,097	$51,371	$83,906	19
J0638	CANAKINUMAB (PF) 150 MG/ML SUBCUTANEOUS SOLUTION	$85,619	$41,097	$124	$83,906	32
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$37,855	$47,319	$77,288	19
J9334	EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11200 UNIT/5.6 ML SUBCUT SOLN	$78,865	$37,855	$33,912	$77,288	30
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$37,132	$46,415	$75,811	19
J3241	TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION	$77,358	$37,132	$333	$75,811	32
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$36,926	$46,158	$75,391	19
J2507	PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION	$76,930	$36,926	$3,392	$75,391	32
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$34,878	$43,597	$71,209	19
J9298	NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION	$72,662	$34,878	$31,245	$71,209	30
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$33,736	$42,170	$68,877	19
J1628	GUSELKUMAB 200 MG/2 ML SUBCUTANEOUS SYRINGE	$70,283	$33,736	$139	$68,877	32
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$31,963	$39,953	$65,257	19
J3245	TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE	$66,589	$31,963	$140	$65,257	32
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$29,029	$36,286	$59,268	19
J3357	USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SOLUTION	$60,477	$29,029	$153	$59,268	32
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$28,181	$35,226	$57,536	19
J9042	BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION	$58,710	$28,181	$253	$57,536	32
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$27,207	$34,009	$55,548	19
J9272	DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION	$56,682	$27,207	$24,373	$55,548	30
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$27,099	$33,874	$55,327	19
J9043	CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION	$56,456	$27,099	$232	$55,327	32
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$27,004	$33,755	$55,134	19
J9022	ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION	$56,259	$27,004	$91.86	$55,134	32
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$26,257	$32,821	$53,608	19
J1640	HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION	$54,702	$26,257	$31.35	$53,608	32
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$25,246	$31,557	$51,543	19
J9144	DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN	$52,595	$25,246	$53.4	$51,543	32
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$25,134	$31,418	$51,315	19
J2329	UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION	$52,363	$25,134	$22,516	$51,315	30

Showing top 50 of 11,000 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.